Stephen J Moss Selected Research

K Cl- Cotransporters

1/2022	Inhibiting with-no-lysine kinases enhances K+/Cl- cotransporter 2 activity and limits status epilepticus.
6/2018	Locally Reducing KCC2 Activity in the Hippocampus is Sufficient to Induce Temporal Lobe Epilepsy.
11/2017	Molecular architecture of potassium chloride co-transporter KCC2.
10/2016	Compromised GABAergic inhibition contributes to tumor-associated epilepsy.
7/2014	Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen J Moss Research Topics

Disease

15	Epilepsy (Aura) 01/2022 - 10/2002
8	Seizures (Absence Seizure) 01/2022 - 01/2010
7	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 12/2007
6	Schizophrenia (Dementia Praecox) 01/2020 - 01/2007
5	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 08/2003
4	Substance-Related Disorders (Drug Abuse) 01/2017 - 10/2002
3	Neoplasms (Cancer) 01/2019 - 01/2010
3	Nervous System Diseases (Neurological Disorders) 08/2013 - 10/2004
2	Mood Disorders (Mood Disorder) 12/2020 - 01/2007
2	Bipolar Disorder (Manic Depressive Psychosis) 12/2020 - 10/2009
2	Fragile X Syndrome (Martin Bell Syndrome) 01/2019 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2017
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017 - 01/2017
2	Ischemia 08/2010 - 01/2007
1	Hyperammonemia 01/2022
1	Amyloid Plaque 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 12/2020
1	Postpartum Depression (Post-Natal Depression) 12/2020
1	Chorea (Rheumatic Chorea) 01/2020
1	Autistic Disorder (Autism) 11/2017
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2017
1	Frontotemporal Dementia (Semantic Dementia) 01/2017
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2017
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 11/2016
1	Pathologic Processes 11/2016
1	Glioma (Gliomas) 10/2016
1	Idiopathic Generalized Epilepsy 07/2014
1	AIDS-Related Complex (ARC) 01/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2012
1	Memory Disorders (Memory Loss) 09/2012
1	Inflammation (Inflammations) 09/2012
1	Cushing Syndrome 12/2011
1	Encephalitis (Encephalitis, Rasmussen) 01/2010
1	Autoimmune Diseases of the Nervous System 01/2010
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2010
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2010
1	Brain Ischemia (Cerebral Ischemia) 10/2009

Drug/Important Bio-Agent (IBA)

7	gamma-Aminobutyric Acid (GABA)IBA 10/2018 - 12/2007
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2004
5	K Cl- CotransportersIBA 01/2022 - 07/2014
4	BenzodiazepinesIBA 01/2022 - 11/2012
4	EnzymesIBA 01/2020 - 08/2003
3	Diazepam (Valium)FDA LinkGeneric 01/2022 - 08/2013
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2004
3	ChloridesIBA 11/2017 - 12/2007
3	Aminobutyrates (Aminobutyric Acid)IBA 01/2017 - 09/2012
3	GABA-A Receptors (GABA(A) Receptor)IBA 11/2012 - 01/2008
3	GABA-B ReceptorsIBA 01/2010 - 10/2004
2	Amyloid beta-PeptidesIBA 01/2022 - 03/2004
2	4-Aminopyridine (4 Aminopyridine)FDA Link 01/2022 - 01/2016
2	Kainic Acid (Kainate)IBA 01/2022 - 12/2015
2	Glutamic Acid (Glutamate)FDA Link 01/2022 - 10/2016
2	NeurosteroidsIBA 12/2020 - 01/2019
2	ConvulsantsIBA 12/2020 - 12/2015
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2017 - 01/2017
2	Anesthetics (Anesthetic Agents)IBA 11/2016 - 08/2013
2	Pilocarpine (Ocusert)FDA LinkGeneric 10/2010 - 12/2007
2	Hypnotics and Sedatives (Sedatives)IBA 01/2007 - 10/2002
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2007 - 10/2002
2	Messenger RNA (mRNA)IBA 03/2004 - 08/2003
1	WNK463IBA 01/2022
1	nasIBA 01/2022
1	AmmoniaIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	brexanoloneIBA 12/2020
1	zuranoloneIBA 12/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	Threonine (L-Threonine)FDA Link 01/2019
1	LipidsIBA 01/2018
1	Apolipoproteins E (ApoE)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2017
1	GTP-Binding Proteins (G-Protein)IBA 01/2017
1	Potassium Channels (Potassium Channel)IBA 01/2017
1	LigandsIBA 11/2016
1	Bumetanide (Bumex)FDA LinkGeneric 10/2016
1	Potassium Chloride FDA LinkGeneric 10/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	Vesicular Transport Adaptor ProteinsIBA 01/2016
1	Alanine (L-Alanine)FDA Link 03/2015
1	Immunoglobulin E (IgE)IBA 07/2014
1	AMPA Receptors (AMPA Receptor)IBA 01/2014
1	Propofol (Diprivan)FDA LinkGeneric 08/2013
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 08/2011
1	Serine (L-Serine)FDA Link 08/2011
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2011
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2011
1	Tyrosine (L-Tyrosine)FDA Link 10/2010
1	Glutamate Receptors (Glutamate Receptor)IBA 08/2010
1	AntibodiesIBA 01/2010
1	AutoantibodiesIBA 01/2010
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2010
1	AntigensIBA 01/2010
1	PlasticsIBA 01/2009
1	Protein Kinase CIBA 01/2008

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2017
1	Immunotherapy 01/2010